🔎 Trials Near Me

Home › Type 2 Diabetes › Florida › Pembroke Pines

Type 2 Diabetes clinical trials in Pembroke Pines, FL

6 studies for Type 2 Diabetes are looking for participants at sites in and around Pembroke Pines (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

RecruitingPhase 3
  • Center for Diabetes, Obesity and Metabolism, Pembroke Pines
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07064473

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

RecruitingPhase 3
  • Center for Diabetes, Obesity and Metabolism Inc, Pembroke Pines
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07595549

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

RecruitingPhase 3
  • American Research Centers of Florida, Pembroke Pines
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07282600

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

RecruitingPhase 3
  • Center for Diabetes, Obesity and Metabolism Inc, Pembroke Pines
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT07351058

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

RecruitingPhase 2
  • Bolanos Clinical Research, Pembroke Pines
Ages 18 to 80 · All sexes · Updated Sep 11, 2026 · NCT07271186

About Type 2 Diabetes

Type 2 Diabetes, previously referred to as Adult Onset Diabetes, is the more common type. Risk factors include obesity and family history.

More about Type 2 Diabetes on MedlinePlus

Type 2 Diabetes trials in other cities

Other studies in Pembroke Pines

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.